Enhanced diagnosis of HIV-1-associated tuberculosis by relating T-SPOT.TB and CD4 counts

European Respiratory Journal

Volumn 36, Issue 3, 2010, Pages 594-600

  Oni, T ^a,d   Patel, J ^g   Gideon, H P ^a   Seldon, R ^a   Wood, K ^a   Hlombe, Y ^a   Wilkinson, K A ^a,e   Rangaka, M X ^a,b,f   Mendelson, M ^c   Wilkinson, R J ^a,d,e  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^g Brighton and Sussex University Hospitals   (United Kingdom)

Author keywords

Diagnosis; HIV 1; Interferon ; Management; Mycobacterium tuberculosis

Indexed keywords

CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE DEFICIENCY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SENSITIVITY ANALYSIS; SPUTUM SMEAR; TUBERCULIN TEST;

ADULT; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOSUPPRESSION; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; MALE; MYCOBACTERIUM TUBERCULOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS;

EID: 77952611169     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00171509     Document Type: Article

References (24)

1. World Health Organization. Global Tuberculosis Control 2009: Epidemiology. Strategy. Financing: WHO Report 2009. Geneva, World Health Organization, 2009.
2. Wood R, Maartens G, Lombard CJ. Risk factors for developing tuberculosis in HIV-1-infected adults from communities with a low or very high incidence of tuberculosis. J Acquir Immune Defic Syndr 2000; 23: 75-80. (Pubitemid 30123268)
3. Elliott AM, Hodsdon WS, Kyosiimire J, et al. Cytokine responses and progression to active tuberculosis in HIV-1-infected Ugandans: a prospective study. Trans R Soc Trop Med Hyg 2004; 98: 660-670. (Pubitemid 40029118)
4. Sonnenberg P, Glynn JR, Fielding K, et al. How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. J Infect Dis 2005; 191: 150-158. (Pubitemid 40096371)
5. Elliott AM, Namaambo K, Allen BW, et al. Negative sputum smear results in HIV-positive patients with pulmonary tuberculosis in Lusaka, Zambia. Tuber Lung Dis 1993; 74: 191-194. (Pubitemid 23188682)
6. Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin Infect Dis 1993; 17: 968-975.
7. Duncan LE, Elliott AM, Hayes RJ, et al. Tuberculin sensitivity and HIV-1 status of patients attending a sexually transmitted diseases clinic in Lusaka, Zambia: a cross-sectional study. Trans R Soc Trop Med Hyg 1995; 89: 37-40.
8. Clark SA, Martin SL, Pozniak A, et al. Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease. Clin Exp Immunol 2007; 150: 238-244. (Pubitemid 47609557)
9. Chapman AL, Munkanta M, Wilkinson KA, et al. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS 2002; 16: 2285-2293. (Pubitemid 35449014)
10. Mandalakas AM, Hesseling AC, Chegou NN, et al. High level of discordant IGRA results in HIV-infected adults and children. Int J Tuberc Lung Dis 2008; 12: 417-423.
11. Rangaka MX, Wilkinson KA, Seldon R, et al. Effect of HIV-1 infection on T-cell-based and skin test detection of tuberculosis infection. Am J Respir Crit Care Med 2007; 175: 514-520. (Pubitemid 46354256)
12. Rangaka MX, Diwakar L, Seldon R, et al. Clinical, immunological, and epidemiological importance of antituberculosis T cell responses in HIV-infected Africans. Clin Infect Dis 2007; 44: 1639-1646. (Pubitemid 46871513)
13. Oxford Immunotec. T-SPOT®.TB. www.oxfordimmunotec.com Date last accessed: July 6, 2009.
14. Chen X, Yang Q, Zhang M, et al. Diagnosis of active tuberculosis in China using an in-house gamma interferon enzyme-linked immunospot assay. Clin Vaccine Immunol 2009; 16: 879-884.
15. Chee CB, Gan SH, Khinmar KW, et al. Comparison of sensitivities of two commercial gamma interferon release assays for pulmonary tuberculosis. J Clin Microbiol 2008; 46: 1935-1940.
16. Nishimura T, Hasegawa N, Mori M, et al. Accuracy of an interferon-c release assay to detect active pulmonary and extrapulmonary tuberculosis. Int J Tuberc Lung Dis 2008; 12: 269-274. (Pubitemid 351361896)
17. Kang YA, Lee HW, Hwang SS, et al. Usefulness of whole-blood interferon-c assay and interferon-c enzyme-linked immunospot assay in the diagnosis of active pulmonary tuberculosis. Chest 2007; 132: 959-965.
18. Dewan PK, Grinsdale J, Kawamura LM. Low sensitivity of a whole-blood interferon-c release assay for detection of active tuberculosis. Clin Infect Dis 2007; 44: 69-73. (Pubitemid 44968987)
19. Syed Ahamed Kabeer B, Sikhamani R, Swaminathan S, et al. Role of interferon gamma release assay in active TB diagnosis among HIV infected individuals. PLoS One 2009; 4: e5718.
20. Ewer K, Deeks J, Alvarez L, et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003; 361: 1168-1173. (Pubitemid 36398385)
21. Hill PC, Fox A, Jeffries DJ, et al. Quantitative T cell assay reflects infectious load of Mycobacterium tuberculosis in an endemic case contact model. Clin Infect Dis 2005; 40: 273-278.
22. Ribeiro S, Dooley K, Hackman J, et al. T-SPOT.TB responses during treatment of pulmonary tuberculosis. BMC Infect Dis 2009; 9: 23.
23. Goletti D, Carrara S, Mayanja-Kizza H, et al. Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study. BMC Infect Dis 2008; 8: 11. (Pubitemid 351404645)
24. Aiken AM, Hill PC, Fox A, et al. Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases. BMC Infect Dis 2006; 6: 66. (Pubitemid 44376863)